Real-World Evidence for Regulatory Submissions

With changing industry trends and new legislation, having robust real-world evidence (RWE) for your organization is more important than ever.

In this on-demand webinar, you'll hear from experts as they discuss regulatory submissions and how to select quality data. You'll gain insights into PINC AI Applied Sciences RWE and how its quality data, which represents over one billion individual patient encounters, can be fit-for-purpose* for your regulatory use.

Topics of discussion will also include:

  • Information about recent RWE legislation, including FDA guidance
  • Industry trends and resources for filing regulatory submissions
  • Case studies from submitting RWE for regulatory submissions, including learnings and challenges
  • Leveraging RWE in clinical trials


Myla Maloney
Chief Commercial Officer, Premier, Inc., PINC AI Applied Sciences

Soumi Saha
Senior Vice President of Government Affairs, Premier, Inc.

Watch trailer below or register to view the full webinar.

*designed to meet fit-for-purpose standards by the FDA.


Premier is committed to protecting the privacy and security of any personal information you provide to us. By clicking here, you understand and acknowledge that the personal information that you are submitting on this form is subject to Premier's privacy policy.

Privacy Policy